Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …

Simple Summary Adoption of single-fraction stereotactic body radiation therapy for lung
tumors has been limited among different institutions even during the coronavirus disease …

The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past
decade, in part as the result of several UK clinical trials and a recent NHS England …

Importance Stereotactic ablative radiotherapy (SABR) is used for treating lung tumors but
can cause toxic effects, including life-threatening damage to central structures …

Purpose The benefit of local consolidative therapy (LCT) for oligometastasis across
histologies remains uncertain. EXTernal beam radiation to Eliminate Nominal metastatic …

Clinical trials frequently include multiple end points that mature at different times. The initial
report, typically based on the primary end point, may be published when key planned co …

Purpose A systematic review of treatment characteristics, outcomes, and treatment-related
toxicities of stereotactic body radiation therapy (SBRT) for pulmonary oligometastases …

Simple Summary In the present work, we analyzed long-term outcomes of patients with
synchronous oligometastatic (OMD) non-small cell lung cancer (NSCLC) with locally …

This overview summarises the current evidence on efficacy and safety of single-fraction
stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung …

Background and Purpose A survey on the patterns of practice of respiratory motion
management (MM) was distributed to 111 radiation therapy facilities to inform the …